Fostemsavir Tromethamine
1 NDC across 1 manufacturer|0 Generic,1 Brand
Fostemsavir Tromethamine is used to treat HIV infections, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Jul 2, 2020. In 2024, Medicare Part D spent $115 million on Fostemsavir Tromethamine across 13,000 claims for 1,505 beneficiaries.
Fostemsavir Tromethamine is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $156.84 to $156.84 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
0G / 1B
Manufacturers
1
competing in market
Price Spread
$156.84 – $156.84
per EA
7d Activity
avg +0.0% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
ViiV Healthcare Company manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing FOSTEMSAVIR TROMETHAMINE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
RUKOBIA ER 600 MG TABLET | $156.8362 per EA | — |
Frequently Asked Questions
What is Fostemsavir Tromethamine used to treat?
Fostemsavir Tromethamine is used to treat HIV infections, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Fostemsavir Tromethamine?
In 2024, Medicare Part D spent $115 million on Fostemsavir Tromethamine across 13,000 claims for 1,505 beneficiaries.
How many Fostemsavir Tromethamine products are on the market?
The Fostemsavir Tromethamine drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.
What is the price range for Fostemsavir Tromethamine?
NADAC reference prices for Fostemsavir Tromethamine range from $156.8362 to $156.8362 per EA.
Which manufacturers make Fostemsavir Tromethamine?
1 manufacturer lists Fostemsavir Tromethamine in NADAC. Ranked by number of NDCs, the largest are ViiV Healthcare Company (1).